FTM

What FTM does

FTM II is a Nevada-based, privately registered investment fund that operates the "Forget the Market" alternative investment strategy. The fund raises capital by selling Class A Preference Shares to individual investors and channels that working capital into personal injury medical receivables through Olgeta, LLC, its 80%-owned operating subsidiary. Olgeta applies a proprietary evaluation methodology to source receivables—accepting only approximately 1 in 5 candidates—and then manages acquisition, holding, and collection. Each receivable is secured by a legally binding lien between the patient and their attorney, payable from any future lawsuit settlement or insurance recovery. The fund's value proposition rests on structural uncorrelation with equity markets rather than on alpha generation.

The fund's product surface is deliberately narrow: a single strategy, a single share class, and a single underlying asset category. Target customers are individual investors—both beginners and seasoned—who seek low-volatility, low-correlation alternatives to traditional equity exposure; the fund explicitly positions itself against "Wall Street" volatility. Distribution is fully direct: the website hosts subscription applications and redemption forms, and investor engagement is handled via a Las Vegas phone line and contact form, with no intermediaries, placement agents, or broker-dealer relationships disclosed.

Revenue mechanics operate on two layers. First, as the 80% owner of Olgeta, FTM II captures the majority of subsidiary profits generated from receivable collections. Second, Olgeta pays interest on working capital borrowed from FTM II, producing an intra-group interest income stream. The fund discloses no AUM, management fees, performance fees, or minimum investment thresholds. Operating footprint is domestic (US only), headcount is reported at 1–10, and leadership consists of Endre Dobozy (Managing Director and Founder) and Bill Dalzell (Executive Director, CFO, and CCO).

Name

FTM

Legal name

FTM II

Website

https://ftm-investments.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

FTM II is a Nevada-based private investment fund that raises capital via Class A Preference Shares and invests in personal injury medical receivables through its 80%-owned operating subsidiary Olgeta, LLC. It serves individual investors seeking low-correlation alternative assets outside traditional equity markets.

Ownership category

akta.pro rank

Product category

Alternative Investment Fund

NAICS

Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro industry

PRIMARYFSAAABAI

Alternative Investments for Private Wealth (Hedge Funds, PE/VC Access, Private Credit)

Financial & Insurance/Asset & Wealth Management/Private Banking & HNW/UHNW Wealth Management

Keywords

• Alternative investments
• Medical receivables
• Hedge fund
• Personal injury investments
• Portfolio diversification

Headquarters

HQ city

Port Harcourt

HQ country

Nigeria

HQ region

Africa

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Preference Share Capital Raising: FTM II raises capital by selling preference shares to investors. The funds generated serve as working capital and are loaned to Olgeta, LLC (the subsidiary). This is the primary mechanism for generating investment capital for the fund's operations.
2. Subsidiary Profit Distribution: FTM II holds 80% ownership stake in Olgeta, LLC. As the primary owner, FTM II benefits from Olgeta's profits generated through the acquisition and collection of medical receivables.
3. Interest on Intercompany Loans: Olgeta pays interest on funds borrowed from FTM II. This creates a dual revenue generating stream where the fund earns interest income on the working capital loaned to its subsidiary.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

FTM II operates as a registered alternative investment fund that raises capital by selling Class A preference shares to investors. The capital raised is loaned to its 80%-owned subsidiary Olgeta, LLC, which uses the working capital to evaluate, acquire, and collect personal injury medical receivables secured by attorney liens and payable by insurance companies.

Product overview

FTM II operates as a single unified alternative investment fund offering the "Forget the Market" strategy. The fund's core product is a low-risk investment vehicle focused on personal injury medical receivables, where capital raised through Class A Preference Shares is loaned to its operating subsidiary Olgeta, LLC. Olgeta evaluates and acquires medical receivables, manages collections, and generates returns that flow back to FTM II investors. The fund structure provides dual revenue streams: profit distributions from Olgeta and interest on loaned funds.

Differentiator

Problem solved

Functional benefit

Products and services

• FTM II "Forget the Market" Investment Fund A registered alternative investment fund that pools investor capital to acquire personal injury medical receivables, providing returns uncorrelated with traditional equity markets. Designed for both beginner and seasoned investors seeking low-risk, stable returns.
• Class A Preference Shares Capital-raising instrument sold to investors via subscription applications. Funds raised are loaned to Olgeta, LLC to acquire medical receivables, generating returns that flow back to shareholders.

Quantifiable outcome

• No correlation to traditional equity markets
• +3 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Olgeta, LLCcoreStrategic or Co-development PartnerFTM II holds an 80% ownership stake in Olgeta, LLC, which is responsible for all operational activities related to generating returns from medical receivables. Olgeta is the primary operating entity that acquires, evaluates, manages, and collects payments on medical receivables. The relationship includes intercompany lending where FTM II loans working capital to Olgeta, and Olgeta pays interest on those funds.

Scale indicators6 records

Recent moves3 records

Expansion highlights1 record

Emerging players

• Masterworks: Art-investment platform allowing individuals to buy shares in single artworks as an uncorrelated alternative asset. Comparable to FTM II on the 'non-correlated alternative asset sold via share-like instruments to retail investors' axis, though the underlying asset (art vs. PI receivables) is different.
• AcreTrader: Farmland investment platform offering fractional ownership of agricultural land to individual investors. Comparable as a 'niche real-asset alternative investment platform accessible to retail investors,' though the asset class (farmland vs. medical receivables) is entirely different.
• Rally Rd: Platform allowing individuals to buy fractional interests in collectible alternative assets (classic cars, watches, etc.). Comparable to FTM II on the 'unconventional alt-asset sold via fractional share-like instruments to retail/HNW investors' angle, but in a tangential asset class.
• Percent (formerly Cadence): Private credit marketplace that securitizes and sells tranched participation in short-duration, income-generating private credit transactions to investors. Comparable to FTM II on the structured private-debt / receivables angle and selective underwriting of short-duration cash-flowing assets.

Direct peers

• PeerStreet: Private real estate debt investment platform that sources, underwrites, and acquires loans, then distributes fractional interests to investors. Highly analogous operating model to FTM II: short-duration receivables acquired at a discount, pooled for investors, with rigorous originator underwriting as the core differentiation.
• YieldStreet: Online alternative investment platform offering individual investors access to income-generating assets such as private credit, structured notes, and legal-finance receivables. Most direct comparable to FTM II: matches the model of pooling investor capital to acquire specialized, non-correlated receivables distributed to retail/HNW investors.
• Republic (Republic.co): Private investment platform offering access to alternative assets — including private credit, real estate, and venture — to retail and accredited investors. Overlaps with FTM II on retail-facing alternative-investment distribution and preference-share-like securities, though FTM II's niche is narrower (medical receivables).
• Worthy Bonds: Investment platform offering interest-bearing bonds to retail investors backed by small-business lending receivables. Comparable to FTM II as a registered-style fund alternative selling securities to individuals, targeting conservative investors seeking predictable yields outside equity markets.

Broad incumbents

• Fundrise: Largest US retail-facing alternative investment platform, focused on private real estate funds offered via eREIT and interval fund structures. Comparable distribution model and investor profile to FTM II but a much larger incumbent operating in a different alternative-asset vertical.

Regional players

• Prestamos Investments (Legalfin): Specialized lender/fund focused on legal finance and pre-settlement funding, including medical receivables. The most directly comparable business in the same niche as FTM II/Olgeta, though typically operating on the lending side rather than as a registered pool vehicle.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ftmmutual

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FTM